Personal stem cells tested to fight rare brain disease
NCT ID NCT07465198
Summary
This study is testing whether a treatment using a patient's own stem cells can help slow the progression of Multiple System Atrophy (MSA), a rare and serious brain disease. It will involve 50 participants, who will be randomly assigned to receive either the stem cell treatment or a placebo. The main goal is to see if the treatment improves movement, daily function, and quality of life over 48 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MSA - MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BioCells Medical
Warsaw, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.